(Press-News.org) Measuring the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy should help boost survival of young leukemia patients by better matching patients with the right intensity of chemotherapy. St. Jude Children's Research Hospital investigators led the research, which appears in the March 20 edition of the journal Lancet Oncology.
The findings stem from a study of 498 children and adolescents with acute lymphoblastic leukemia (ALL) enrolled in a St. Jude-led protocol between 2000 and 2007. The clinical trial was the first to use measurement of residual leukemia cells - or minimal residual disease (MRD) - in bone marrow to help guide therapy. St. Jude pioneered MRD measurement as a tool to guide leukemia treatment.
"This analysis shows that MRD-directed therapy clearly contributed to the unprecedented high rates of long-term survival that patients in this study achieved," said first and corresponding author Ching-Hon Pui, M.D., chair of the St.Jude Department of Oncology. Overall, 93.5 percent of patients were alive five years after their cancer was diagnosed. "MRD proved to be a powerful way to identify high-risk patients who needed more intensive therapy and helped us avoid over-treatment of low-risk patients by reducing their exposure to chemotherapy," Pui said.
Researchers hope the findings will expand use of MRD measurements to guide leukemia treatment in children and adults.
The technique might also help identify patients who could be cured with less intensive chemotherapy, Pui said. Overall long-term survival was 97.9 percent or better for 244 patients in this study classified as low risk based on a variety of factors including their age at diagnosis and MRD of less than 1 percent on day 19 of treatment. "Given the excellent outcome, it will be important to determine if treatment can be further reduced in this subgroup of patients," Pui said.
In countries with limited resources, Pui said the findings suggest that results of MRD on day 19 can be used to reduce treatment-related deaths by identifying patients who will likely be cured with low-intensity chemotherapy. "This study demonstrates these patients have an extremely low risk of relapse," he said.
The study showed that measuring MRD just twice during remission induction therapy - at day 19 and day 46 - rather than multiple times during the more than two years of treatment was sufficient to guide treatment of most pediatric ALL patients. That will help save money and protect patients from the discomfort and risks associated with bone marrow aspiration for MRD testing. MRD measurements should continue, however, to guide treatment of patients with detectable MRD on day 46 of treatment. That is a level of 0.01 percent or more, which translates into one leukemia cell in 10,000 normal cells.
MRD was not a perfect predictor of relapse risk. Cancer returned in 26 of the 430 patients with undetectable MRD when treatment ended after 120 weeks. Researchers are working to develop even more sensitive methods for tracking treatment response in order to identify those at risk for having their cancer return.
Overall, researchers showed that regardless of other risk factors, including age at diagnosis or the initial white blood cell count, patients with an MRD level of 1 percent or more on day 19 of therapy were far less likely than other young leukemia patients to be alive and cancer-free 10 years later. Having detectable leukemia cells on day 46 of treatment was also associated with lower survival.
MRD levels on days 19 and 46 led to the reclassification of 50 patients from low risk to a higher risk leukemia that warranted more intensive therapy. Researchers credited the change with boosting survival.
INFORMATION:
The other authors are Deqing Pei, Sima Jeha, Cheng Cheng, John Sandlund, Raul Ribeiro, Jeffrey Rubnitz, Hiroto Inaba, Deepa Bhojwani, Tanja Gruber, Wing Leung, James R. Downing, William Evans and Mary Relling, all of St. Jude; Elaine Coustan-Smith and Dario Campana, both of the National University of Singapore; and W. Paul Bowman, of the University of North Texas Health Sciences Center, Fort Worth, Texas.
The research was funded in part by grants (CA21765, CA36401, GM92666) from the National Institutes of Health and ALSAC.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food--because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.
MANHATTAN, Kansas -- Kansas State University scientists have released findings of a complex, two-year study of the genomic diversity of wheat that creates an important foundation for future improvements in wheat around the world.
Their work has produced the first haplotype map of wheat that provides detailed description of genetic differences in a worldwide sample of wheat lines. In genetics, a haplotype map is a powerful tool for transferring sequence-level variation to multiple gene mapping projects.
"All of these new, genomic-based strategies of breeding promise ...
EAST LANSING, Mich. - Recycling plastic works; additives to biodegrade plastic do not.
A new study from Michigan State University shows that several additives that claim to break down polyethylene (i.e., plastic bags) and polyethylene terephthalate (i.e., soda bottles) simply don't work in common disposal situations such as landfills or composting.
"Making improper or unsubstantiated claims can produce consumer backlash, fill the environment with unwanted polymer debris and expose companies to legal penalties," said Susan Selke, co-author of the study and MSU packaging ...
The March 2015 issue of Language, the flagship scholarly journal of the Linguistic Society of America, is now available online:
https://muse.jhu.edu/journals/language/toc/lan.91.1.html
Highlights of the March issue include a paper on the origins of Indo-European languages which has already been the subject of significant interest, as well as the inaugural article of Language's new online section for "Phonological Analysis".
"Ancestry-constrained phylogenetic analysis supports the Indo-European steppe hypothesis", by Will Chang, Chundra Cathcart, David Hall and Andrew ...
A plant scientist from The Australian National University (ANU) has called for the United Nations to guarantee free and open access to plant DNA sequences to enable scientists to continue work to sustainably intensify world food production.
Dr Norman Warthmann, a plant geneticist at the ANU Research School of Biology, has lodged a submission with the UN, which is currently considering issues to include in its 2015 Global Sustainable Development Report.
Food security depends on an acceleration in plant breeding, which could be threatened by private companies restricting ...
The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick.
The research findings could potentially lead to patients being tested for osteoarthritis and diagnosed several years before the onset of physical symptoms.
Conducted by the University's Medical School, the research identified a biomarker linked to both rheumatoid and osteoarthritis.
Whilst there are established tests for rheumatoid arthritis (RA), the newly identified biomarker could lead to one which can diagnose both rheumatoid arthritis and osteoarthritis ...
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
In an addendum, the Institute now examined information subsequently submitted by the manufacturer in the commenting procedure: According to the findings, there is an indication of added benefit; however, the extent is ...
Adapting to climate change could have profound environmental repercussions, according to a new study from the University of East Anglia.
Research in Nature Climate Change reveals that adaptation measures have the potential to generate further pressures and threats for both local and global ecosystems.
Lead researcher Dr Carlo Fezzi, from UEA's School of Environmental Sciences, said: "Climate change is a just a little bit more complicated than we previously thought. We need to take into account not only the direct impact of climate change, but also how people will respond ...
Scientists should reduce antibiotic use in lab experiments - according to a researcher at the University of East Anglia.
Microbiology, molecular biology and genetic research such as the Human Genome Project use antibiotics in experiments.
But it all adds to the global problem of antibiotic resistance according to Dr Laura Bowater, from UEA's Norwich Medical School.
A new article published today in the Journal of Antimicrobial Chemotherapy highlights the problem.
Dr Bowater said: "The discovery of antibiotics was heralded as a magic bullet for modern medicine. Using ...
This news release is available in French. In 1971 there were 139,000 Canadians aged 85 and over. By 2013 their numbers had risen to 702,000. The Oldest Old as they have become known today represent 2% of the total Canadian population. "They are a demographic reality which has to be taken into account in formulating public policy", according to Jacques Légaré, a demographer at the University of Montreal, who is presenting a report on this phenomenon this week to more than a hundred experts meeting at the Population Change and Lifecourse Strategic Knowledge ...
Suspending kids from school for using marijuana is likely to lead to more -- not less -- pot use among their classmates, a new study finds.
Counseling was found to be a much more effective means of combating marijuana use. And while enforcement of anti-drug policies is a key factor in whether teens use marijuana, the way schools respond to policy violators matters greatly.
The study, conducted by researchers at the University of Washington and in Australia, compared drug policies at schools in Washington state and Victoria, Australia, to determine how they impacted ...
